2 Comments
 

Based on the most helpful WSO content, here are some strategies to source investors for your fundraising project in the biotech space:

  1. Networking:

    • Directly network your way to the buyside. This can be more effective than relying solely on databases.
    • Attend industry events, conferences, and seminars where biotech investors are likely to be present.
    • Leverage LinkedIn to connect with potential investors and industry professionals.
  2. Equity Research Reports:

    • Read equity research reports for pre-revenue biotech companies. These reports often mention investors and funds that are active in the space.
  3. Investor Presentations and SEC Filings:

    • Look at the investor presentations and SEC filings of public companies developing similar products. These documents often list current investors and can provide leads.
  4. Clinical Trials Databases:

    • Use clinicaltrials.gov to see which companies are conducting studies similar to your startup. This can help identify investors who have funded similar projects.
  5. Consulting with Experts:

    • If possible, consult with the biotech team at your firm or other industry experts who can provide insights and introductions.
  6. PhD and Postdoc Networks:

    • Engage with PhD and postdoc networks, as many junior/mid-level VCs in top biotech funds have advanced degrees and can provide valuable connections.
  7. Angel Investor Networks:

    • Join angel investor networks and platforms that focus on biotech and deep tech investments.
  8. Online Databases:

    • While you mentioned limited buying power, some online databases offer free trials or limited access that can still be useful. Examples include Crunchbase, AngelList, and PitchBook.

By combining these strategies, you can create a comprehensive list of potential biotech investors who can deploy capital quickly for your fundraising project.

Sources: Biotech finance: from IB to VC / HF to funded startup, Biotech finance part 2: valuation methodologies and modeling considerations, Healthcare / Biotech Venture Capital?, Biotech finance part 2: valuation methodologies and modeling considerations, How Do I Get Smart in Biotechnology Space?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Unde perspiciatis sit possimus quo excepturi est illo. Praesentium culpa labore repellat a et dolor. Magni dolorem voluptas voluptate necessitatibus ducimus expedita aperiam. Debitis est maiores est explicabo repellat soluta. Exercitationem quae repellat voluptates. Quis repellendus ipsum eos dolor.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”